[thomaskay]

If I had a site with bundles of impressions coming out of my ears like myspace, facebook, etc etc I'd be rubbing my hands with glee about phorm.

But for anyone with a niche or expensive audience, their ad revenue is going to be diluted as advertisers start to buy ads via OIX of audiences that have been to the specialist site, but are now on a cheaper site.

Personally I think both sides should be recompensed... the phorm model seems to be that only the retargeting site gets the dosh.

I'm sure phorm will go ahead no problemo despite all the concerns. I'm sure they'll make alot of money. But.... they're going to carve into the adrevenue of sites that are genuinely adding unique and good content to the web.